These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1291 related items for PubMed ID: 17379045

  • 1. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM, Boyce E, Guyer J, Nuzum D.
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [Abstract] [Full Text] [Related]

  • 3. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
    Guay DR.
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325
    [Abstract] [Full Text] [Related]

  • 4. Pregabalin: a new neuromodulator with broad therapeutic indications.
    Shneker BF, McAuley JW.
    Ann Pharmacother; 2005 Dec; 39(12):2029-37. PubMed ID: 16288079
    [Abstract] [Full Text] [Related]

  • 5. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [Abstract] [Full Text] [Related]

  • 7. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T, van Seventer R, Murphy TK.
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [Abstract] [Full Text] [Related]

  • 8. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF, Horga A.
    Rev Neurol; 2010 Oct; 42(4):223-37. PubMed ID: 16521062
    [Abstract] [Full Text] [Related]

  • 9. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM, Powe KW, Cates ME.
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [Abstract] [Full Text] [Related]

  • 10. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I, Wajsbrot D, Therrien F, Lemay J.
    Clin J Pain; 2011 Mar; 27(3):185-93. PubMed ID: 21178603
    [Abstract] [Full Text] [Related]

  • 11. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA, Murphy JA.
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [Abstract] [Full Text] [Related]

  • 12. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
    Nymdelger S, Nieber K.
    Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
    [Abstract] [Full Text] [Related]

  • 13. Pregabalin: an antiepileptic agent useful for neuropathic pain.
    Blommel ML, Blommel AL.
    Am J Health Syst Pharm; 2007 Jul 15; 64(14):1475-82. PubMed ID: 17617497
    [Abstract] [Full Text] [Related]

  • 14. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM, Almas M, Emir B, Giordano S, Leon T.
    Curr Med Res Opin; 2011 Jul 15; 27(7):1285-93. PubMed ID: 21561392
    [Abstract] [Full Text] [Related]

  • 15. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS, Nissen LM, O'Callaghan JP, Duffull SB, Smith MT, Moore BJ.
    J Pain; 2010 May 15; 11(5):462-71. PubMed ID: 19962354
    [Abstract] [Full Text] [Related]

  • 16. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T, Freynhagen R, Versavel M, Trostmann U, Young JP.
    Eur J Pain; 2008 Feb 15; 12(2):203-13. PubMed ID: 17631400
    [Abstract] [Full Text] [Related]

  • 17. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
    Vinik A, Emir B, Cheung R, Whalen E.
    Clin Ther; 2013 May 15; 35(5):612-23. PubMed ID: 23541708
    [Abstract] [Full Text] [Related]

  • 18. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U, Griesing T, Emir B, Young JP.
    Am J Ther; 2010 May 15; 17(6):577-85. PubMed ID: 20393345
    [Abstract] [Full Text] [Related]

  • 19. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America.
    Xochilcal-Morales M, Castro EM, Guajardo-Rosas J, Obregón TN, Acevedo JC, Chucan JM, Plancarte-Sanchez R, Davila G, Wajsbrot D, Guerrero M, Vinueza R.
    Int J Clin Pract; 2010 Aug 15; 64(9):1301-9. PubMed ID: 20487048
    [Abstract] [Full Text] [Related]

  • 20. Pregabalin for peripheral neuropathic pain.
    Hadj Tahar A.
    Issues Emerg Health Technol; 2005 Mar 15; (67):1-4. PubMed ID: 15806748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.